• Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective

    May 1, 2018, 00:00

  • A Cross Sectional Study of the Factors that Affect Therapy Adherence in Children with Attention Deficit Disorder/ Attention Deficit/Hyperactivity Disorder

    May 1, 2018, 00:00

  • The Reporting Quality of Pharmacoeconomic Studies Before and After Publication of the Cheers Checklist

    May 1, 2018, 00:00

  • Profiles Of Non-Small Cell Lung Cancer Patients Treated With Immuno-Oncology Therapies In The United States And Western Europe

    May 1, 2018, 00:00

  • Rate and Reimbursement of Ankle Screw Removal Procedures after Syndesmotic Fixation

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib for Third-Line Metastatic Colorectal Cancer (MCRC) Compared to Cetuximab Plus Irinotecan in China

    May 1, 2018, 00:00

  • Complications Related Health Utility Decrements for Type 2 Diabetes Population in the United States

    May 1, 2018, 00:00

  • Emergency Department (ED) Utilization for Dental Or Oral Health Related Conditions (DOHRC) Before and after Implementation of Affordable Care Act (ACA)

    May 1, 2018, 00:00

  • Ventilator-Associated Pneumonia- Validity of Quality Metrics and Outcomes of Current Practices

    May 1, 2018, 00:00

  • A Modified Parametric Approach to Model Long-Term Survival of Potentially Curative Therapies- Implications for the Cost-Effectiveness of Car-T Therapies

    May 1, 2018, 00:00

  • The Economic Impact of Shingles Vaccine Disparities Among Hispanics

    May 1, 2018, 00:00

  • Evaluating and Valuing Drugs for Rare Conditions- No Easy Answers

    May 1, 2018, 00:00

  • Cost-Benefitanalysis of Hepatitis B Vaccination Strategies for Preventing Mother-to-Child Transmission：A Decision Tree-Markov Model

    May 1, 2018, 00:00

  • Development and Preliminary Assessment of the Environment-Based Quality Of Life (EBQOL) Instrument

    May 1, 2018, 00:00

  • Budget Impact Analysis of two Approved Therapies for Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00

  • Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B- Standard half-Life Vs. Extended Half-Life Products

    May 1, 2018, 00:00

  • Drug Utilization Review of Acute Coronary Syndrome Patients in Hong Kong and United States

    May 1, 2018, 00:00

  • Budget Impact Analysis of Implementing 5mm Dual-Ended Safety Pen Needles for Insulin Injections in US Hospitals

    May 1, 2018, 00:00

  • Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commer ...

    May 1, 2018, 00:00

  • Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis

    May 1, 2018, 00:00

  • The Economic Burden of Varicella in Mexico

    May 1, 2018, 00:00

  • Comparative Effectiveness of Second-Line Anti-Diabetic Agents in Delaying Treatment Intensification

    May 1, 2018, 00:00

  • Does Exposure to Health Valuation Tasks Impact One’s Self Rated Health?

    May 1, 2018, 00:00

  • Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States

    May 1, 2018, 00:00

  • Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model- the Case of Second-Line Treatment in Patients with Ovarian Cancer

    May 1, 2018, 00:00

  • A Systematic Review of Health Economic Evaluations in Mexico

    May 1, 2018, 00:00

  • Total Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country- Is Cost Data Distribution Comparable with High Income Countries?

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States

    May 1, 2018, 00:00

  • Identifying Priority Regions for Improving Treatment Options for Illicit Drug Dependence

    May 1, 2018, 00:00

  • Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog

    May 1, 2018, 00:00

  • Consumer Preferences for Precision Medicine Technologies- Evidence from A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients- Analysis of the American Burn Association National Burn Repository

    May 1, 2018, 00:00

  • A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors

    May 1, 2018, 00:00

  • Challenges in Valuing Temporary Health States for Economic Evaluation- A Review of Empirical Applications of the Chained Time Trade-Off Method

    May 1, 2018, 00:00

  • Disease Burden and Integreted Disease Management of Biologic Treated Psoriasis Patients with Psoriatic Arthritis in Clinical Practi Results from Multicountry Study in EU5

    May 1, 2018, 00:00

  • Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Eviden The Case of Second Line Treatment for Ovarian Cancer

    May 1, 2018, 00:00

  • Readiness of Community Oncology and Urology Practices for Value-Based Care

    May 1, 2018, 00:00

  • Pharmacoeconomics in Nepal- Need For A Paradigm Shift

    May 1, 2018, 00:00

  • Comparing the Costs and Outcomes of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Cephalomedullary Nail (Single-Screw Nail) in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00

  • Non-Inferiority Clinical Trial Design, Drug Approval, and Implications For Clinicians in Prescribing Oral Anticoagulants

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Costs Among Commercially Insured Patients with Juvenile Idiopathic Arthritis (JIA) in the United States

    May 1, 2018, 00:00

  • The Impact of Patient-Centered Medical Home on Hypertension-Associated Health Care Utilization and Cost

    May 1, 2018, 00:00

  • Unmet Needs in the Management of Hypoactive Sexual Desire Disorder in Premenopausal Women

    May 1, 2018, 00:00

  • Adverse Drug Reactions (ADRS) Associated with Medications used to Treat HIV/AIDS- 2001-Present

    May 1, 2018, 00:00

  • Cost - Effectiveness of the use of the Insulin Pump Therapy Versus Daily Multiple Injections in Patients with Type 1 Diabetes at the Mexican Institute of Social Security

    May 1, 2018, 00:00

  • Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US - A Cross-Sectional Analysis

    May 1, 2018, 00:00

  • Do Medical Homes Affect Healthcare Utilization Rates? A Longitudinal Evaluation on Medical Home Implementation in Italy

    May 1, 2018, 00:00

  • Differences in the Flexibility of Muscles of Athletes Doing Weight Training and Functional Training

    May 1, 2018, 00:00

  • Medication Usage, Length of Stay, and Hospital Charges in Bipolar Disorder Patients- A Retrospective Analysis of a Large Us Electronic Health Record Database

    May 1, 2018, 00:00

  • Cost Treatment Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Ca ...

    May 1, 2018, 00:00

  • Predictors of All-Cause Healthcare Payments Among Patients With Treatment-Resistant Major Depressive Disorder

    May 1, 2018, 00:00

  • A Systematic Literature Review of Methodology to Determine Treatment Persistence in Inflammation and Immunology Observational Database Studies

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hereditary Angioedema- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)

    May 1, 2018, 00:00

  • Trends in Approval of Therapeutic Biologic Approved by the US Food and Drug Administration (1986–2017)

    May 1, 2018, 00:00

  • Economic Value Tool Evaluating Total Procedural Costs Associated with the Creation of Colorectal Anastomoses

    May 1, 2018, 00:00

  • Economic Impact of Treatment Adherence in Exocrine Pancreatic Insufficiency (EPI) Patients Treated with Pancreatic Enzyme Replacement Therapy (PERT)

    May 1, 2018, 00:00

  • Influence Of Critical Disease Insurance (CDI) Policy On Pemetrexed Adherence Among The First-Line Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients In Zhejiang Province Of China

    May 1, 2018, 00:00

  • Ultrafiltration vs. Diuretics for the treatment of Fluid Overload in Heart Failure Patients- A Hospital Cost Analysis

    May 1, 2018, 00:00

  • Latest Insights on the Cost Efficiency of Therapeutic Plasma Exchange in Treating Guillain-Barre Syndrome

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Intraabdominal Infection

    May 1, 2018, 00:00

  • Financial Impact and Experience with General Medical Services Among Cancer Survivors in the United States

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sequential Treatment Strategies with Tnf-Inhibitors in Patients with Ankylosing Spondylitis- A Patient-Level Simulation Model

    May 1, 2018, 00:00

  • Inclusion of Drugs in a Formulary- A Case Study

    May 1, 2018, 00:00

  • Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy- A Retrospective Claims Database Analysis

    May 1, 2018, 00:00

  • Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

    May 1, 2018, 00:00

  • Converting Eortc QLQ-C30 Scores To EQ-5D Utility Scores in the Brigatinib Alta Study

    May 1, 2018, 00:00

  • Risk of Diabetes Among Intensive and Moderate Dose Statin Users with Potential Modifying Effects of Treatment Duration

    May 1, 2018, 00:00

  • Evaluation of Cost of Hospitalizations Related to Nausea and Vomiting Among Cancer Patients

    May 1, 2018, 00:00

  • Globalization Module for A Diabetes Progression Prediction Model- The Building, Relating, Acting, and Validating Outcomes (Bravo) Model

    May 1, 2018, 00:00

  • Economic Evaluation of Enterex® IMX, A Specialized Nutrition Supplement Containing Arginine, in the Treatment of Neurocritical Patients in México

    May 1, 2018, 00:00

  • Market Access Challenges and Opportunities for Anti-Infectives- An EU5 Perspective

    May 1, 2018, 00:00

  • Impact of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Utilization and Healthcare Costs Among Individuals with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • Cost-Effectiveness of Transcathether Aortic Valve Implantation with the New Repositionable Self-Expandable Evolut R Versus Corevalve System in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00

  • Updated New Drugs Approval Timing in Italy (2015-2017)

    May 1, 2018, 00:00

  • Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device- Results of a Randomized Equivalence Trial

    May 1, 2018, 00:00

  • Prevalence, Disease Burden and Unmet Needs of Patients With Essential Tremor- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Racial Disparity in the Use of First-Line Psychosocial Care For Children and Adolescents Initiating Therapy on Antipsychotics

    May 1, 2018, 00:00

  • Measuring the Extent and Impact of Disease Sub-Specialization Among Neurologists in the US

    May 1, 2018, 00:00

  • Estimation of Total Burden of Bladder Cancer in Brazil – An Economic and Clinical Approach

    May 1, 2018, 00:00

  • Global Burden of Seasonal Influenza Disease- A Structured Literature Review

    May 1, 2018, 00:00

  • Long-Term Benefits of Employee Wellness Programs- A Blue Cross Blue Shield of Louisiana (BCBSLA) Case Study

    May 1, 2018, 00:00

  • Time for Reimbursement for Orphan Drugs in EU5

    May 1, 2018, 00:00

  • Early Check- A Voluntary Newborn Screening Program and Research Registry to Facilitate Clinical Trials in Pre-Symptomatic Infants with Rare Diseases

    May 1, 2018, 00:00

  • Characteristics and Rate of Subsequent Lumbar Spine Fusion Surgery Among Patients Treated with Allogenic Cellular Bone Matrix for Posterior Lumbar Spinal Fusion

    May 1, 2018, 00:00

  • Simultaneous Development of Patient-Reported Outcome Measures for Masseter Muscle Hypertrophy in An Asia Population

    May 1, 2018, 00:00

  • Real-World Treatment Patterns For Patients With Head And Neck Squamous Cell Carcinoma (HNSCC) Treated With Immuno-Oncology (IO) Therapy

    May 1, 2018, 00:00

  • Evaluation of Modified Item Characteristics on Item Comprehension and Psychometric Performance

    May 1, 2018, 00:00

  • A Value Of Information (VOI) Analysis Of Evolocumab For The Prevention Of Cardiovascular Deaths And Incidences In Secondary Prevention Patients

    May 1, 2018, 00:00

  • Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?

    May 1, 2018, 00:00

  • Identifying Community-Reported Health Priorities Using Free Listing Interviews in a Mixed Methods Approach

    May 1, 2018, 00:00

  • Efficacy and Safety of Vedolizumab in the Treatment of Ulcerative Colitis- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Demonstration of Ngram Frequency and Cluster Method for Identifying Signals of Transfusion Reactions (TR)

    May 1, 2018, 00:00

  • Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States

    May 1, 2018, 00:00

  • Hypoactive Sexual Desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”- Challenges with the Characterization of HSDD in Women

    May 1, 2018, 00:00

  • Small Changes, Big Differences? Cohort Variation by Parameter Specifications in Claims-Based Drug use Evaluations

    May 1, 2018, 00:00

  • Characterizing the Clinical and Economic Burden of Type 2 Diabetes (T2DM) Patients on Multiple Daily Injections (MDI) of Insulin- A Systematic Literature Review

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China

    May 1, 2018, 00:00

  • Efficacy and Safety Analysis of Radium-223 in Patients with Prostate Cancer Castration-Resistant and Bone Metastasis

    May 1, 2018, 00:00

  • Anti-Vegf Dosing Intervals in Patients with Neovascular Age-Related Macular Degeneration- a Retrospective Cohort Study in Australia

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Bronchial Thermoplasty Versus Pharmacological Therapies in Patients with Severe Asthma in Mexico, Colombia and Spain

    May 1, 2018, 00:00

  • Validation of a Claims-Based Algorithm for Identification of Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the US

    May 1, 2018, 00:00

  • Regular Physical Activity- Impact on Health Care Utilization Patterns and Expenses in a Cohort of Overweight and Obese US Adults with Diabetes

    May 1, 2018, 00:00

  • Resource Use Related to Pediatric Lower Limb Spasticity in Canada- Physician Questionnaire

    May 1, 2018, 00:00

  • Psychometric Validation of the 1-Month Recall Uterine Fibroid Symptom and Health-Related Quality-of-Life Questionnaire

    May 1, 2018, 00:00

  • The Total Direct Healthcare Expenditures of Diagnosed Drug Dependen Evidence from United States National Survey Data

    May 1, 2018, 00:00

  • Implantable Cardiac Monitor Compared with Conventional Diagnostic for Unexplained Syncope- A Combined Cost-Effectiveness and Budget-Impact Analysis

    May 1, 2018, 00:00

  • Effect of Patient Involvement in Treatment Decision Making on Disease Outcomes in Rheumatoid Arthritis in the EU5

    May 1, 2018, 00:00

  • Chi-Square Automatic Interaction Detection (CHAID) Analysis- Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy

    May 1, 2018, 00:00

  • An Exact Method For Estimating Standard Errors From Zero-Inflated Gamma Distributions For Healthcare Cost Data

    May 1, 2018, 00:00

  • What US Healthcare Providers Value in Genomic Precision Medicine- A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Creating a Flexible Continuous Procedure Distribution Model Based on Pre-Test Risk Level for Lung Cancer in Patients with Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia

    May 1, 2018, 00:00

  • Estimated Budget Impact Of Cholesterol Decreasing In The Russian Population

    May 1, 2018, 00:00

  • Treatment Patterns and Costs of Care in Commercially-Insured and Medicaid Patients with Transfusion-Dependent SS-Thalassemia

    May 1, 2018, 00:00

  • Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)

    May 1, 2018, 00:00

  • Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany

    May 1, 2018, 00:00

  • Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study

    May 1, 2018, 00:00

  • Exploring Cost Savings of a Modified Plerixafor Protocol for Use in Autologous Stem Collection

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective

    May 1, 2018, 00:00

  • What Is The Future Of Indication-Based Pricing And Contracting (IBPC) For Market Access Of New Oncologic And Biologic Agents In Major Global Markets?

    May 1, 2018, 00:00

  • The Costs of Intensifying Type 2 Diabetes Patients Treated with Basal Insulin to Basal in Combination with GLP-1- A Physician Survey

    May 1, 2018, 00:00

  • Assessing the Trends in the use of Fluoroquinolones Before and after FDA Notice of its Restricted use in Uncomplicated Infections

    May 1, 2018, 00:00

  • Cost - Effectiveness Analysis of Ultrasound Screening for Thyroid Cancer in Asymptomatic Population

    May 1, 2018, 00:00

  • Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly

    May 1, 2018, 00:00

  • Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis- A Systematic Review

    May 1, 2018, 00:00

  • Economic Impact of Generic Antiretrovirals in France for HIV Patient’s Care- A Simulation Between 2018 and 2022

    May 1, 2018, 00:00

  • New Estimates of the Willingness-to-Pay for a Statistical Life Year- A Systematic Review of the Empirical Economic Literature

    May 1, 2018, 00:00

  • Tumor Necrosis Factor Inhibitor Therapy and The Risk of Developing Depression Among Working-Age Adults with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • The Direct Cost Burden of Tuberous Sclerosis Complex Among Insured Patients in the US

    May 1, 2018, 00:00

  • A Predictive Modeling Approach that Accurately Identifies Members with the Likelihood of Having a Future Costly Event

    May 1, 2018, 00:00

  • Patient and Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practi Findings from the OM1 Data Cloud

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Analyzing Prescription Data to Target Hard-To-Identify Patient Populations for Clinical Trials- A Case Study in Narcolepsy

    May 1, 2018, 00:00

  • A Review of Definition of Smoking Status When Using Electronic Medical/Health Records and Claims Databases In Studies

    May 1, 2018, 00:00

  • Use of Anti-Diabetic Medication is Not Associated with Cancer Risk in Chinese Patients with Type 2 Diabetes

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Low Back Pain- A Systematic Review

    May 1, 2018, 00:00

  • Health Care Utilization and Economic Burden of Patients With Inflammatory Bowel Disease in the US Department of Defense Population

    May 1, 2018, 00:00

  • Deficit of the Hungarian Health Insurance Fund Between 1994-2014

    May 1, 2018, 00:00

  • Developing Content for a New Generic Qaly Measure- Results from a Qualitative Literature Review (E-Qaly Project)

    May 1, 2018, 00:00

  • New Oral Anticoagulants And The Risk Of Vasculitis- A Nested Case-Control Study

    May 1, 2018, 00:00

  • The Association Between Adherence with Statin Therapy and Risk of Dementia Among Diabetic Patients with Comorbid Hyperlipidemia

    May 1, 2018, 00:00

  • Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Pneumococcal Vaccines Produce Substantial Cost-Savings in Mexico

    May 1, 2018, 00:00

  • A Comparison Of Patient Level Data (IPD) Regression Techniques In Adjusting For Cross Trial Differences In An Indirect Treatment Comparison (ITC)- A Worked Example Of Simulated Treatment Comparison (STC) Vs Bayesian Ipd Regression

    May 1, 2018, 00:00

  • An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma

    May 1, 2018, 00:00

  • Testosterone Replacement Therapy Reduces Cardiovascular Events in Men with Chronic Kidney Disease

    May 1, 2018, 00:00

  • Adherence Issues in Osteoarthritis- How can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Evaluation of Current And Future PD-(L)1 Testing Requirements in the US

    May 1, 2018, 00:00

  • Hospitalization Outcomes For Adults In The United States With Atrial Septal Defect- Analysis Of A Multicenter Database

    May 1, 2018, 00:00

  • Effectiveness of the Treatment with New Antivirals in Adult Patients with Chronic Infection with Hepatitis C Virus in Colombia During 2016-2017

    May 1, 2018, 00:00

  • Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00

  • Market Access for Advanced Therapy Medicinal Products (ATMPS) Begins at the Bench

    May 1, 2018, 00:00

  • The Prevalence and Treatment Patterns of Women of Child Bearing Age (WOCBA) with Psoriasis (PSO)

    May 1, 2018, 00:00

  • Interseizure Interval In Frequently Admitted Epilepsy Patients

    May 1, 2018, 00:00

  • The Role of General Practitioners During Economic Crises

    May 1, 2018, 00:00

  • Management of Biosimilars- Key Considerations for Pharmacists in Patient Care

    May 1, 2018, 00:00

  • A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

    May 1, 2018, 00:00

  • Perceived Cancer Risk and Evaluation of Public Awareness of Direct-to-Consumer Genetic Tests in the United States

    May 1, 2018, 00:00

  • Evaluating A Conceptual Platform for Facilitating and Scaling Pharmaceutical Risk Sharing Arrangements

    May 1, 2018, 00:00

  • A Tale of Two Universal Health Insurance Schemes in One Country- Horizontal Inequality of Government Medical and Pharmaceutical Benefits for Australian Children

    May 1, 2018, 00:00

  • Cost-Effectiveness of Abaloparatide for the Treatment of Postmenopausal Women with Osteoporosis

    May 1, 2018, 00:00

  • Growth of Hospital-Owned Specialty Pharmacies- Importance and Implications for Manufacturer Channel and Patient Access Strategies

    May 1, 2018, 00:00

  • Resource use of Patients Diagnosed with Schizophrenia- Analysis of Physician Record form Data in the United States

    May 1, 2018, 00:00

  • Trends in Prescription Opioid Use Among Hemodialysis Patients in the United States, 2007-2014

    May 1, 2018, 00:00

  • Adherence and Persistence in Medication Assisted Treatment Among Pregnant Women with Opioid use Disorder

    May 1, 2018, 00:00

  • Budget Impact Analysis of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration in Mexico

    May 1, 2018, 00:00

  • Is Self-Rated Health of Americans Different in 2017 Compared to 2002?

    May 1, 2018, 00:00

  • Prevalence of Anxiety Symptoms and its Correlates Among Medical Students in China- A National Survey in 33 Universities

    May 1, 2018, 00:00

  • Ultrasound- A Fast Low-Cost Tool for the Diagnosis of Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • Predictive Model Directed Interventions Improve Medication Adherence Program Efficiency

    May 1, 2018, 00:00

  • How Health Technology Assessment Programs Take Into Account the Patient Perspective in Healthcare Decision Making- Comparison Between the United States and Several European Countries

    May 1, 2018, 00:00

  • Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

    May 1, 2018, 00:00

  • Persistence and Adherence at 12 Months with Subcutaneously Administered Biologics Among Biologic-Naive and -Experienced Patients With Psoriatic Arthritis- Analyses From A Us Claims Database

    May 1, 2018, 00:00

  • Cost-Effectiveness and Return on Investment of Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Pressure Injuries in the Critical Care Setting

    May 1, 2018, 00:00

  • Impact Of Dining Out And Food Intake Pattern On Atrial Fibrillation Prevalence In Hong Kong Chinese Elders

    May 1, 2018, 00:00

  • Infant Mortality from Acute Respiratory Infections and Armed Conflict- An Exploratory Analysis

    May 1, 2018, 00:00

  • Payer Perspectives on Gene Therapy Reimbursement in the United States

    May 1, 2018, 00:00

  • Copyright/Subscription

    May 1, 2018, 00:00

  • Using Machine Learning to Predict Opioid Overdoses Among Prescription Opioid Users

    May 1, 2018, 00:00

  • Patient Characteristics And Treatment Patterns From Spear-Bladder- Study Informing Treatment Pathway Decision In Bladder Cancer

    May 1, 2018, 00:00

  • Incremental Burden of Diabetes Complications on Quality of Life and Healthcare Expenditures in the United States

    May 1, 2018, 00:00

  • Extended Thromboprophylaxis With Betrixaban Is Cost-Effective In Acutely ILL Medical Patients

    May 1, 2018, 00:00

  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Peru

    May 1, 2018, 00:00

  • The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Healthcare Resource Utilization Among Patients with Angelman Syndrome Stratified By Age

    May 1, 2018, 00:00

  • Budget Impact Analysis For Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Costa Rica

    May 1, 2018, 00:00

  • Medical Expenditures for Patients with Pulmonary Embolism Among the Population with Urban Basic Health Insurance in China

    May 1, 2018, 00:00

  • Systematic Review of Diagnosis and Treatment of Obesity and Bing- Eating Syndrome

    May 1, 2018, 00:00

  • The Burden of Sickle Cell Disease

    May 1, 2018, 00:00

  • A Review of Patient-Reported Outcomes in Nonalcoholic Steatohepatitis (NASH)

    May 1, 2018, 00:00

  • Prescription Drug Coverage for Treatment of Low Back Pain Among U.S. Medicaid, Medicare Advantage and Commercial Insurers

    May 1, 2018, 00:00

  • The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00

  • Cost Effectiveness Of Direct Oral Anticoagulants (DOACS) Compared With Warfarin- A Literature Review

    May 1, 2018, 00:00

  • Poor Medication Adherence and High Rates of Treatment Discontinuation Among SCD Patients Treated with Hydroxyurea

    May 1, 2018, 00:00

  • Utilization, Spending, and Prices Trends for Anti-Epileptic Drugs (AEDS) in the U.S. Medicaid Programs- Empirical Data Analysis from 2010 to 2016

    May 1, 2018, 00:00

  • Predictors of Annual Salary for Health Economics, Outcomes Research, and Market Access Professionals

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada

    May 1, 2018, 00:00

  • Treatment Patterns and Medicaid Spending in Comorbid Schizophrenia Populations- Once-Monthly Paliperidone Palmitate Vs Oral Atypical Antipsychotics

    May 1, 2018, 00:00

  • Patterns of Treatment and Recurrence In Patients with Non-Metastatic Melanoma WHO Underwent Lymph Node Dissection Surgery

    May 1, 2018, 00:00

  • Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Commercial Health Plan Perspective

    May 1, 2018, 00:00

  • The Problem of Rarity- Estimation of Prevalence in Rare Disease

    May 1, 2018, 00:00

  • Comparative Efficacy of Consolidation Therapy After Chemoradiation Therapy (CRT) in Patients with Unresectable, Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Direct Medical Costs Among Adult Patients with Chronic Hepatitis C in China

    May 1, 2018, 00:00

  • EQ-5D-3L Decrements By Diabetes Complications and Comorbidities in China

    May 1, 2018, 00:00

  • Oncology Combination Pricing- Impact of Product Characteristics and Unmet Need

    May 1, 2018, 00:00

  • Non-Adherence to Antipsychotics and Disease Comorbidity- A Double Whammy in Schizophrenia Management

    May 1, 2018, 00:00

  • Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00

  • Clinical Outcome Assessments- Use of Normative Data in a Pediatric Rare Disease

    May 1, 2018, 00:00

  • Treatment Patterns Of Alk+ Non-Small Cell Lung Cancer Patients In The United States And Western Europe

    May 1, 2018, 00:00

  • Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management

    May 1, 2018, 00:00

  • Feminine Hygiene Product Use and Awareness Among Young Us Adults

    May 1, 2018, 00:00

  • Cervical Cancer Screening Decision Model

    May 1, 2018, 00:00

  • Improved Quality Control With Subcutaneous (SC) Infusion Pump

    May 1, 2018, 00:00

  • Comparing Cost-Per-Qalys Gained And Cost-Per-Dalys Averted Analyses

    May 1, 2018, 00:00

  • Using Real World Data to Establish An Optimal Treatment Target for HBA1C in Diabetes Type 2

    May 1, 2018, 00:00

  • Systematic Review of Patient Perspectives and Quality of Life Outcomes Associated with Use of Topical Interventions for Treatment of Chronic Wounds

    May 1, 2018, 00:00

  • Armed Conflict and Infant Mortality Due to Diarrhea in Colombian Children

    May 1, 2018, 00:00

  • Valuing Health-Related Quality of Life for Inpatients with Diabetes-Related Complications In China

    May 1, 2018, 00:00

  • A 2-Arm Randomized Pilot Study To Evaluate The Impact Of A Mobile Health Application On Medication Adherence In Patients On Oral Anti-Cancer Medications

    May 1, 2018, 00:00

  • Assessing Symptom Change at the Individual Level Using Item Response Theory Versus Sum Scoring- Implications for Depression Treatment

    May 1, 2018, 00:00

  • Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States- An Empirical Analysis Based On MEPS Database 2007-2014

    May 1, 2018, 00:00

  • Inpatient Admission Length Of Stay And Costs Among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared To Patients Receiving Surgical Cutdown For Closure Of Large Bore Arterial Access

    May 1, 2018, 00:00

  • Clinical, Humanistic, and Economic Burden of Osteoarthritis (OA) Among Noninstitutionalized Adults in the United States (US)

    May 1, 2018, 00:00

  • Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States

    May 1, 2018, 00:00

  • Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib

    May 1, 2018, 00:00

  • Real World Practice and Patient-Reported Outcomes of Uncontrolled Hypertensive Patients In Korea

    May 1, 2018, 00:00

  • Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

    May 1, 2018, 00:00

  • Characterizing Patients Treated With Macitentan For Pulmonary Arterial Hypertension (PAH) In The U.S. Opsumit Users Registry (OPUS)

    May 1, 2018, 00:00

  • Costs Related to Infusion Therapy Room and Staff for Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • Statins Adherence And Its Risk Factors Analysis in Chinese Ascvd Patients Based on A Provincial Claim Data

    May 1, 2018, 00:00

  • Emergent Therapies And Egfr Mutation Testing In Non-Small Cell Lung Cancer- Real-World Practices

    May 1, 2018, 00:00

  • Reimbursement Decision-Making in Ukraine- Current and Future Directions

    May 1, 2018, 00:00

  • Evaluation On Use Of Digital Refill Reminders On Patient Adherence To Antiretroviral Medications

    May 1, 2018, 00:00

  • Challenges in Outlier Surgeon Assessment in the Era of Public Reporting

    May 1, 2018, 00:00

  • Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia

    May 1, 2018, 00:00

  • Hospital Related Clinical and Economical Outcomes of a Bicruciate Knee System in Total Knee Arthroplasty Patients

    May 1, 2018, 00:00

  • An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer

    May 1, 2018, 00:00

  • Real World Experience with Calcipotriene and Betamethasone Dipropionate Foam 0.005%/0.064% (Cal/BD Foam) in the Treatment of Adult Psoriasis Including Psoriasis Itch from Retrospective Chart Review

    May 1, 2018, 00:00

  • Evaluation of Electronic Health Record Data Quality to Assess the Clinical Indices of Anemia in Dialysis Patients

    May 1, 2018, 00:00

  • Serum Autoantibodies Multi-Testing in Rheumatoid Arthritis in Primary Care can Reduce Avoidable Costs Associated to False Positives. A Simulation Study in the United States of America

    May 1, 2018, 00:00

  • FDA Orphan Exploitation? Are Pharma’s Approaches to Orphan Oncology Drug Approval Fuelling a Push for Reform By the FDA?

    May 1, 2018, 00:00

  • New Drugs Approval in Italy- Updated Analysis of the Applied Negotiation Conditions 2015-2017

    May 1, 2018, 00:00

  • Utilization Patterns Of The First US Biosimilar, Filgrastim-Sndz, Observed Between 2015 And 2017 In A Medical Transcription Database

    May 1, 2018, 00:00

  • Humanistic And Economic Burden Associated With Anxiety And Depression Among Adults With Diabetes And Hypertension

    May 1, 2018, 00:00

  • Access to Patient-Centered Medical Home Care Among Adults with Chronic Conditions- Findings from the Medical Expenditures Panel Survey

    May 1, 2018, 00:00

  • Lifetime Cost-Effectiveness of Adjuvant External Beam Whole Breast Irradiation (EBWBI) in Estrogen Receptor Positive (ER+) Early-Stage Breast Cancer (ESBC) Women- Cardiotoxicity Consideration

    May 1, 2018, 00:00

  • Selecting Health States for EQ-5D-3L Valuation Studies- Statistical Considerations Matter

    Apr 1, 2018, 00:00

  • Table of Contents

    Apr 1, 2018, 00:00

  • A Framework for Measuring Low-Value Care

    Apr 1, 2018, 00:00

  • Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV- A Systematic Literature Review

    Apr 1, 2018, 00:00

  • Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly- A Prospective Cohort Study

    Apr 1, 2018, 00:00

  • Editorial Board

    Apr 1, 2018, 00:00

  • Utility-Based Instruments for People with Dementia- A Systematic Review and Meta-Regression Analysis

    Apr 1, 2018, 00:00

  • Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

    Apr 1, 2018, 00:00

  • The CDI-DaySyms- Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection

    Apr 1, 2018, 00:00

  • Copyright/Subscription

    Apr 1, 2018, 00:00

  • Modeling Clinical Outcomes in Prostate Cancer- Application and Validation of the Discrete Event Simulation Approach

    Apr 1, 2018, 00:00

  • Are US Health Insurers Efficient or Not?

    Apr 1, 2018, 00:00

  • The Use of MCDA in HTA- Great Potential, but More Effort Needed

    Apr 1, 2018, 00:00

  • Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population

    Apr 1, 2018, 00:00

  • A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures

    Apr 1, 2018, 00:00

  • Emerging Good Practices for Transforming Value Assessment- Patients’ Voices, Patients’ Values

    Apr 1, 2018, 00:00

  • What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

    Apr 1, 2018, 00:00

  • Improving Value for Patients with Eczema

    Apr 1, 2018, 00:00

  • The Value Challenge- Examining the Transformative Strategies to Measure or Evaluate the Value of Health Care Interventions

    Apr 1, 2018, 00:00

  • Comparing 15D Valuation Studies in Norway and Finland—Challenges When Combining Information from Several Valuation Tasks

    Apr 1, 2018, 00:00

  • Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance

    Mar 1, 2018, 00:00

  • Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease

    Mar 1, 2018, 00:00

  • Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients

    Mar 1, 2018, 00:00

  • Table of Contents

    Mar 1, 2018, 00:00

  • What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?

    Mar 1, 2018, 00:00

  • Paying for Cures- Perspectives on Solutions to the “Affordability Issue”

    Mar 1, 2018, 00:00

  • The ICER Value Framework- Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

    Mar 1, 2018, 00:00

  • Resource Use and Cost of Alzheimer’s Disease in France- 18-Month Results from the GERAS Observational Study

    Mar 1, 2018, 00:00

  • Copyright/Subscription

    Mar 1, 2018, 00:00

  • Resolving the “Cost-Effective but Unaffordable” Paradox- Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts

    Mar 1, 2018, 00:00

  • Editorial Board

    Mar 1, 2018, 00:00

  • Affordability Challenges to Value-Based Pricing- Mass Diseases, Orphan Diseases, and Cures

    Mar 1, 2018, 00:00

  • Affordability of Health Care- A Global Crisis

    Mar 1, 2018, 00:00

  • The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension

    Mar 1, 2018, 00:00

  • Affordability of New Technologies- The Next Frontier

    Mar 1, 2018, 00:00

  • Real-World Evidence- Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

    Mar 1, 2018, 00:00

  • Estimating the Learning Curve of a Novel Medical Device- Bipolar Sealer Use in Unilateral Total Knee Arthroplasties

    Mar 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- A Missed Opportunity for ISPOR and Patients

    Feb 1, 2018, 00:00

  • The Impact of Decision Makers’ Constraints on the Outcome of Value of Information Analysis

    Feb 1, 2018, 00:00

  • Defining Elements of Value in Health Care—A Health Economics Approach- An ISPOR Special Task Force Report [3]

    Feb 1, 2018, 00:00

  • Editorial Board

    Feb 1, 2018, 00:00

  • A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Frameworks- Serving the Needs of Decision Making

    Feb 1, 2018, 00:00

  • Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

    Feb 1, 2018, 00:00

  • Investigating the Heterogeneity in Women’s Preferences for Breast Screening- Does the Communication of Risk Matter?

    Feb 1, 2018, 00:00

  • Choice Defines Value- A Predictive Modeling Competition in Health Preference Research

    Feb 1, 2018, 00:00

  • Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease

    Feb 1, 2018, 00:00

  • Review of Recent US Value Frameworks—A Health Economics Approach- An ISPOR Special Task Force Report [6]

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Introduction- An ISPOR Special Task Force Report [1]

    Feb 1, 2018, 00:00

  • Copyright/Subscription

    Feb 1, 2018, 00:00

  • Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach- An ISPOR Special Task Force Report [4]

    Feb 1, 2018, 00:00

  • Table of Contents

    Feb 1, 2018, 00:00

  • Corrections to ’Systematic Literature Review and Indirect Treatment Comparison of the Efficacy of Semaglutide versus Empagliflozin as Add-On to Basal Insulin (PDB4)’

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- Seeking a Role for Health Economics

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Feb 1, 2018, 00:00

  • An Overview of Value, Perspective, and Decision Context—A Health Economics Approach- An ISPOR Special Task Force Report [2]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- An Industry Perspective

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- The Use of Cost-Effectiveness Research in Decision Making among US Insurers

    Feb 1, 2018, 00:00

  • Corrections to ‘Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0’ [JVAL 20/8 (2017) 1009–1022]

    Feb 1, 2018, 00:00

  • Approaches to Aggregation and Decision Making—A Health Economics Approach- An ISPOR Special Task Force Report [5]

    Feb 1, 2018, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Systematic Review and Network Meta-Analysis

    Feb 1, 2018, 00:00

  • Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

    Jan 1, 2018, 00:00

  • Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States

    Jan 1, 2018, 00:00

  • Accounting for Uncertainty in Decision Analytic Models Using Rank Preserving Structural Failure Time Modeling- Application to Parametric Survival Models

    Jan 1, 2018, 00:00

  • Table of Contents

    Jan 1, 2018, 00:00

  • Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care

    Jan 1, 2018, 00:00

  • Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices- An Application for Eliciting Patient Preferences for Diabetes Treatments

    Jan 1, 2018, 00:00

  • Editorial Board

    Jan 1, 2018, 00:00

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis- An Indirect Comparison Using Individual Patient Data from Randomized Trials

    Jan 1, 2018, 00:00

  • Instructions for Authors

    Jan 1, 2018, 00:00

  • Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes

    Jan 1, 2018, 00:00

  • Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening- Results from a Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2

    Jan 1, 2018, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available- A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

    Jan 1, 2018, 00:00

  • An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

    Jan 1, 2018, 00:00

  • Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically- Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies

    Jan 1, 2018, 00:00

  • EQ-5D- Moving from Three Levels to Five

    Jan 1, 2018, 00:00

  • EQ-5D-5L versus EQ-5D-3L- The Impact on Cost Effectiveness in the United Kingdom

    Jan 1, 2018, 00:00

  • Trading Bankruptcy for Health- A Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Letter to the Editor- Emerging Guidelines for Patient Engagement in Research

    Dec 1, 2017, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions- An Illustration for Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2017, 00:00

  • Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease

    Dec 1, 2017, 00:00

  • An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions- The EQ-5D Case Study

    Dec 1, 2017, 00:00

  • Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands- A Country Adaptation Analysis Under the Former and Current Du ...

    Dec 1, 2017, 00:00

  • The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life, Work Productivity And Activity Impairment Associated With Clostridium Difficile Infection In China, Brazil, Europe and The United States

    Oct 1, 2017, 00:00

  • When And Where To Use Furigana? The Application Of Phonetic Notation In Japanese Translations Of Clinical Outcomes Assessments (COAS) For Children

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00

  • Burden of Hospitalizations Related To Spinal Tumors in Fran Evolution Between 2012 and 2014

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Afatinib Versus Gefitinib in Egfr-Mutated Population with Advanced Non-Small-Cell Lung Cancer in France

    Oct 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Antineoplásicos De Maior Impacto Financeiro No Instituto Nacional De Cancer Do Brasil

    Oct 1, 2017, 00:00

  • Conceptual Modeling Framework for Global Functioning of Adhd Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban In Patients With Non-Valvular Atrial Fibrillation In Hong Kong

    Oct 1, 2017, 00:00

  • Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary

    Oct 1, 2017, 00:00

  • To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Glioblastoma Multiforme (GBM) Patients Treated at the Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Dispute Issues About The Healing And Health Promotion Of Children

    Oct 1, 2017, 00:00

  • The Utilisation Of Biosimilar Infliximab By English Acute Trusts

    Oct 1, 2017, 00:00

  • A Retrospective Premier Database Study To Compare Repair of Ventral Hernia With Phasixtm VS Stratticetm In The Inpatient Hospital Surgical Setting

    Oct 1, 2017, 00:00

  • Real World Evidence in Glaucomatous Diseases- Emr Data is Indispensible For Understanding Patient Journeys and Optimizing Care

    Oct 1, 2017, 00:00

  • Intensity Modulated Radiation Therapy In Malignant Pleural Mesothelioma; A Piolt For Treatment Outcomes And Cost-Effective Expectations

    Oct 1, 2017, 00:00

  • Análisis Comparativo De Costos Entre Trastuzumab Para Administración Subcutánea En Comparación Con La Formulación Para Administración Intravenosa Desde La Perspectiva De La Seguridad Social Costarricense

    Oct 1, 2017, 00:00

  • Analysis of Drug Utilisation Data Sources to Enable Nationwide Value-Based Pricing of Medicines Across Healthcare Systems in Europe

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions

    Oct 1, 2017, 00:00

  • Real-World Data Analysis of Cancer Treatment Cost Drivers By Type and Place of Service

    Oct 1, 2017, 00:00

  • Health Economic Analysis Of Pneumococcal Conjugated Vaccines For Mexico, Under A Technical Parity Scenario

    Oct 1, 2017, 00:00

  • Effects of Adherence to Pharmacological Secondary Prevention After Myocardial Infarction on Healthcare Expenditures

    Oct 1, 2017, 00:00

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

    Oct 1, 2017, 00:00

  • Characterization And Approximation Of The Direct Costs Of Axial And Peripheral Spondyloarthritis In A Clinical Management Center In Colombia

    Oct 1, 2017, 00:00

  • Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings

    Oct 1, 2017, 00:00

  • 10 Years Of Reimbursement Decisions In The Netherlands- An Overview

    Oct 1, 2017, 00:00

  • Economic Burden of Autism and Autism-Related Spectrum Disorders (Asd) In EU5 Countries

    Oct 1, 2017, 00:00

  • Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer

    Oct 1, 2017, 00:00

  • Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • An Evidence-Based Approach to Predict Long-Term Patient Outcomes and Key Value Drivers

    Oct 1, 2017, 00:00

  • Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation

    Oct 1, 2017, 00:00

  • Impact of Metabolic Surgery on Cost and Long-Term Health Outcome- A Cost-Effectiveness Approach

    Oct 1, 2017, 00:00

  • 90-Day Mortality And Its Predictors In Men With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

    Oct 1, 2017, 00:00

  • Descalonamento Da Terapia Antimicrobiana- Uma Estratégia De Racionalização E Custo-Minimização Em Cenário Privado De Saúde No Ceará

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65 (current)
  • 66
  • 67
  • 68
  • 69
  • 70
  • »